You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

long-acting β2-agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tiotropium and Olodaterol in Comparison to Triple Therapy

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium and Olodaterol (Tio+Olo)
  • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
  • Andover, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

Active, not recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium (Tio)
  • +4 more
  • Taipei, China
    National Tawain University Hospital
Jan 9, 2023

Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)

Recruiting
  • Healthy
  • Salbutamol 400mcg
  • +2 more
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Sep 5, 2023

Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Brussels, Belgium
    Erasme University Hospital
Jun 23, 2023

Moderate Asthma Trial (Long-Acting Beta Agonist)

Not yet recruiting
  • Moderate Asthma
  • Long-Acting Beta Agonist
  • (no location specified)
Feb 24, 2023

Exacerbation Risk in Asthma

Completed
  • Asthma
  • White Plains, New York
    eMax Health
Aug 12, 2022

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Asthma Trial in Worldwide (Rilzabrutinib, )

Recruiting
  • Asthma
  • Berazategui, Buenos Aires, Argentina
  • +24 more
Dec 29, 2022

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Asthma Trial in United States (RPT193, Placebo)

Recruiting
  • Asthma
  • San Jose, California
  • +5 more
Jul 12, 2023

Cancer-Related Pain Trial in Philadelphia (Use of buprenorphine with FAO > 30 OME, CPM Rx application use)

Recruiting
  • Cancer-Related Pain
  • Use of buprenorphine with FAO > 30 OME
  • CPM Rx application use
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jun 9, 2023

Cisgender Female Patients Who Start on Long Acting Cabotegravir

Not yet recruiting
  • Hiv
  • Cabotegravir Injection [Apretude]
  • Orlando, Florida
  • +2 more
Nov 17, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Asthma Trial in Worldwide (Tezepelumab)

Recruiting
  • Asthma
  • Tezepelumab
  • Newport Beach, California
  • +102 more
Jan 11, 2023

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Taiwan, China
    Health Data Research Center, National Taiwan University
Jan 3, 2023

HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

Not yet recruiting
  • HIV-1-infection
  • +2 more
  • CAB + RPV
  • (no location specified)
Nov 16, 2022

Fixed-dose Dual Bronchodilator in Heart Insufficiency and COPD

Withdrawn
  • COPD
  • Spiolto® Respimat® (Tiotropium / Olodaterol)
  • Aachen, North Rhine Westphalia, Germany
    Clinic of Cardiology, Angiology, Pneumology and Intensive Medici
Oct 25, 2022

COPD Trial in Llanelli (Any LABA/LAMA)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Any LABA/LAMA
  • Llanelli, Carmarthenshire, United Kingdom
    Prince Philip Hospital
Aug 2, 2022

Diabetes, Type 2 Trial in Washington (Semaglutide, Placebos)

Recruiting
  • Diabetes Mellitus, Type 2
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

Not yet recruiting
  • HIV
  • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
  • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
  • (no location specified)
Nov 13, 2023

Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

Not yet recruiting
  • Idiopathic CD4 Lymphopenia
  • Recombinant human interleukin (IL) 7-hyFc
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Tiotropium and Olodaterol in Comparison to LABA/ICS

Completed
Has Results
  • COPD
  • Watertown, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

IVF, Infertility Trial in Mansoura (estradiol plus progesterone 100 mg IM injection, Progesterone IM of 100 mg)

Completed
  • IVF
  • Infertility
  • estradiol plus progesterone 100 mg IM injection
  • Progesterone IM of 100 mg
  • Mansoura, Dekahlia, Egypt
    Mansoura Integrated fertility center
Jun 14, 2022